一名膀胱癌伴复发性血尿患者发生的产酸勒克菌尿路感染。
Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria.
作者信息
Li Jonathan, Park Alyssa, Fulmer Brant R, Garg Tullika
机构信息
Department of Urology, Geisinger, Danville, PA, USA.
Department of Population Health Sciences, Danville, PA, USA.
出版信息
Urol Case Rep. 2021 Jan 27;36:101579. doi: 10.1016/j.eucr.2021.101579. eCollection 2021 May.
Abstract
is an rare human pathogen, mostly affecting immunocompromised individuals or as one microbe in polymicrobial infections in immunocompetent patients. is rarely isolated from the urinary tract. We describe a case of pan-sensitive isolated from a polymicrobial urinary tract infection from an immunocompetent older adult with recently diagnosed bladder cancer.
摘要
是一种罕见的人类病原体，主要影响免疫功能低下的个体，或作为免疫功能正常患者多微生物感染中的一种微生物。很少从泌尿道分离出来。我们描述了一例从一名近期诊断为膀胱癌的免疫功能正常的老年成年人的多微生物尿路感染中分离出的全敏感菌株的病例。
相似文献
1
Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria.
Urol Case Rep. 2021 Jan 27;36:101579. doi: 10.1016/j.eucr.2021.101579. eCollection 2021 May.
2
as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility Testing.
Pathogens. 2021 Oct 28;10(11):1399. doi: 10.3390/pathogens10111399.
3
Leclercia adecarboxylata: a case report and literature review of 74 cases demonstrating its pathogenicity in immunocompromised patients.
Infect Dis (Lond). 2019 Mar;51(3):179-188. doi: 10.1080/23744235.2018.1536830. Epub 2018 Nov 29.
4
Leclercia adecarboxylata: An Emerging Pathogen Among Pediatric Infections.
Cureus. 2020 May 10;12(5):e8049. doi: 10.7759/cureus.8049.
5
Leclercia adecarboxylata isolation: case reports and review.
J Clin Diagn Res. 2014 Dec;8(12):DD03-4. doi: 10.7860/JCDR/2014/9763.5260. Epub 2014 Dec 5.
6
Leclercia adecarboxylata in an immunocompetent patient.
J Med Microbiol. 2008 Jul;57(Pt 7):896-898. doi: 10.1099/jmm.0.47673-0.
7
Leclercia adecarboxylata Bacteremia without a Focus in a Non-Immunosuppressed Patient.
Am J Case Rep. 2021 Mar 30;22:e929537. doi: 10.12659/AJCR.929537.
8
invasive infection in a patient with Hirschsprung disease: A case report.
Ann Med Surg (Lond). 2021 Oct 9;71:102927. doi: 10.1016/j.amsu.2021.102927. eCollection 2021 Nov.
9
Leclercia adecarboxylata bacteremia in a trauma patient: case report and review of the literature.
Surg Infect (Larchmt). 2012 Feb;13(1):63-6. doi: 10.1089/sur.2010.093. Epub 2012 Jan 4.
10
Hospital-acquired pneumonia due to Leclercia adecarboxylata in a neurosurgical centre.
J Postgrad Med. 2015 Apr-Jun;61(2):123-5. doi: 10.4103/0022-3859.153108.
引用本文的文献
1
Resistance phenotype and virulence potential of strains isolated from different sources.
Microbiology (Reading). 2024 Apr;170(4). doi: 10.1099/mic.0.001457.
2
Airborne antibiotic resistome and human health risk in railway stations during COVID-19 pandemic.
Environ Int. 2023 Feb;172:107784. doi: 10.1016/j.envint.2023.107784. Epub 2023 Jan 30.
3
infective endocarditis in a man with mitral stenosis: A case report and review of the literature.
World J Clin Cases. 2022 Oct 16;10(29):10670-10680. doi: 10.12998/wjcc.v10.i29.10670.
4
as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility Testing.
Pathogens. 2021 Oct 28;10(11):1399. doi: 10.3390/pathogens10111399.
本文引用的文献
1
Leclercia adecarboxylata: a case report and literature review of 74 cases demonstrating its pathogenicity in immunocompromised patients.
Infect Dis (Lond). 2019 Mar;51(3):179-188. doi: 10.1080/23744235.2018.1536830. Epub 2018 Nov 29.
2
Sepsis and Leclercia adecarboxylata.
QJM. 2018 Oct 1;111(10):733-734. doi: 10.1093/qjmed/hcy131.
3
Natural antimicrobial susceptibility patterns and biochemical profiles of Leclercia adecarboxylata strains.
Clin Microbiol Infect. 2004 Aug;10(8):724-33. doi: 10.1111/j.1469-0691.2004.00892.x.
4
Leclercia adecarboxylata infections: case report and review.
Clin Infect Dis. 1997 Jul;25(1):79-81. doi: 10.1086/514514.
Zotero 插件